A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

EM Shore, M Xu, GJ Feldman, DA Fenstermacher… - Nature …, 2006 - nature.com
EM Shore, M Xu, GJ Feldman, DA Fenstermacher, TJ Cho, IH Choi, JM Connor, P Delai…
Nature genetics, 2006nature.com
Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of
skeletal malformations and progressive extraskeletal ossification. We mapped FOP to
chromosome 2q23-24 by linkage analysis and identified an identical heterozygous mutation
(617G→ A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I
receptor, in all affected individuals examined. Protein modeling predicts destabilization of
the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of …
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification. We mapped FOP to chromosome 2q23-24 by linkage analysis and identified an identical heterozygous mutation (617G → A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I receptor, in all affected individuals examined. Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.
NOTE: In the version of this article initially published, several contributing authors were listed collectively under the name The International FOP Research Consortium. In order to facilitate the electronic citation of author contributions, the authors have chosen to delete the Consortium name and replace it with the names of the individual consortium authors in alphabetical order. This error has been corrected in the HTML and PDF versions of the article.
nature.com